| Question |
Answer |
| Colonization |
Presence of microbe in a host does not cause a specific immune reaction or infection (Do NOT Tx w/ Abx) |
| Empiric Therapy |
Abx choice based on clinically most likely pathogen |
| Definitive Therapy |
Abx choise based on identified pathogen & susceptibilty patterns |
| De-escalation |
Adjustment of Abx regimen from broad to narrow spectrum |
| Collateral Damage |
Unwanted negative effect of an Abx on NMF |
| Minimum Inhibitory Concentration (MIC) |
Minimum [] that inhibits groth of organism |
| Antibiogram |
Compilation of data for bacteria vs. abx |
| Gram (+) Cocci bacteria |
S. Aureus, Staph Epidermidis, Strept Pyogenes, Strep Agalactiae, S. pneumoniae, enterococci, Strp bovis, Viridans Strep, Strep intermedius |
| S. Epidermidis infections |
Associated with "hardware" |
| Enterococci infections |
UTI, appendicitis |
| Strep Bovis Infections |
Bowel lesion = spread of infection |
| Strep. Intermedius Infections |
Abcess Formers |
| Gram (+) Bacilli Bacteria |
**Usually erroneous Sample** Corneybacterium Diptheriae, Listeria Monocytogenes, Bacillus Antracis, Erysipelothrix Rhusiopathiae |
| Listeria Monocytogenes Infections |
Meningitis (Can't eat cheese in 2nd/3rd trimester) |
| Gram (-) Cocci Bacteria |
Neisseria Meningitidis, Neisseria Gonorrhoeae, Moraxella (Branhamella) Catarrhalis |
| Gram (-) Bacilli Bacteria |
Vibrio cholerae, Campylobacter jejuni, H. Pylori, Pseudomonas Aeruginosa, Salmonella, H. Influenza, Brucella, Francisella Tularensis (Tularemia), Pasturella Multocida, Legionella Pneumophilia, Bartonella, Shigella, Enterobacter (E. Coli, etc.) |
| Pasturella Multocida Caused by... |
Bites (Mouths) or Cats & dogs |
| Bartonella caused by... |
Cat scratch |
| Anaerobes |
Clostridium tetani, C. botulinum, C. Difficile, C. Perfringens, Bacteroides, Fusobacterium, Peptostreptococcus, Prevotella |
| Clostridium Perfringens Infection |
Gas Gangrene |
| Beta-Lactum Drugs |
Penicillin, Cephalosporin, Carbapenems, Aztreonam |
| Beta-Lactums MOA |
Interferes with cell wall synthesis |
| Glycoprotein MOA |
Interferes with cell wall synthesis |
| Fluoroquinolones MOA |
Interferes with DNA replication, transcription |
| Rifampin MOA |
Interferes with DNA replication, transcription |
| Aminoglycosides MOA |
Binds to 30s/50s Ribosomal Subunit |
| Macrolides MOA |
Binds to 30s/50s Ribosomal Subunit |
| Ketolides MOA |
Binds to 30s/50s Ribosomal Subunit |
| Oxazolidinones MOA |
Binds to 30s/50s Ribosomal Subunit |
| Tetracyclines MOA |
Binds to 30s/50s Ribosomal Subunit |
| Streptogramins MOA |
Binds to 30s/50s Ribosomal Subunit |
| Broad Spectrum Drugs |
PCN (Penicillin), 3rd/4th generation Cephalosporins, Carbapenems |
| Narrow Spectrum Gram(+) Drugs |
Vancomycin |
| Narrow Spectrum Gram(-) Drugs |
Aminoglycosides, Aztreonam |
| Narrow Spectrum Anaerobes Drugs |
Metronidazole (Flagyl) |
| Pharmacokinetics |
Absorption (Bioavailability), Distribution, Metabolism, Elimination |
| Pharmodynamics |
Relationship between drug concentration & effect "Antibiotic Potency" |
| Bioavailability |
% of oral dose available compared to IV form (100%) |
| Clearance |
Determines steady state of drug (determined by blood flow to metabolizing organ & rate of extraction of the drug from blood) |
| Volume of Distribution |
Relates the amount of drug in the body to the serum drug concentration (Dependent on BMI) |
| Steady State |
After 3 half lives |
| Postantibiotic Effect (PAE) |
Delay before organisms recover & begin growing despite decrease concentration of drug |
| Four Primary Machanisms of Resistance. |
Alterations in outer membrane permeability. Alteration in drug binding sites, Production of molecules capable of inactivating drug molecules. Active efflux of antibiotic from the bacteria. |
| Abx. dosing & duration |
DONT under dose/increase duration = resistance |
| Bacterocidal Drugs |
Beta Lactams, Cephalosporins, quinolones, aminoglycosides |
| Bacterostatic Drugs |
Clindamycin, macrolides, sulfonamides, Tetracycline |
| Aminoglyc. Accumulation |
Nephrotoxic (reversible) & Toxic to the Ear (irreversible) |
| Drugs that penatrate the BBB to the CSF |
AG's, clindamycin |
| Difficult tissue to penetrate |
Bone, synovial fluid, prostate, Abscesses, Peritoneal Fluid |
| DOC |
Drug of Choice |
| IND |
Indications |
| ADR |
Adverse Reactions |
| W/P |
Warnings & Precautions |
| SSSI |
Skin & Soft Tissue Infections |
| Anaphylaxis |
(IgE) Hives (Uticaria). Respiratory Difficulty (Bronchospasm). Swelling. Occurs within the first 72 hours. |
| Most common drug allergy |
Penicillin |
| Penicillin ADR |
Maculopapular rash, rash, uticarial rash, fever, bronchospasm, vasculitis, serum sickness, exfoliative dermatitis, Stevens-Johnson, Anaphylaxis (ordered in decreasing frequency & increasing severity.) |
| Penicillin half life |
Short: 30-60 minutes (rapid renal excretion) |
| Penicillin Types |
Natural, Penicillinase-resistant, Aminopenicillins, Extrended-spectrum ureidopenicillins, B-lactam/B-lactamase Inhibitors |
| Natural Penicillin Drugs & forms |
Penicillin G (IV/IM) & Penicillin V (PO) |
| Natural Penicillin effective against... |
B-hemolytic strept, most anaerobes, viridans strep, N. meningitidis. |
| Natural Penicillin DOC |
Strep. Pneumoniae |
| Natural Penicillin R |
Actinomyces, meningococcus, Pasteurella, S. Pneumoniae, S. pyogenes, T. Pallidum. |
| Natural Penicillin Pregnancy Category |
C |
| Natural Penicillin ADR |
Seizures or hemolytic anemia |
| Penicillinase-resistant penicillins drugs & forms |
Oxacillin/Nafcillin (IV) & Dicloxacillin (PO-empty stomach) |
| Penicillinase-resistant penicillins effective against... |
? |
| Penicillinase-resistant penicillins ADR |
GI cramps, rash, neutropenia (prolonged Rx - especially with nafcillin), acute interstitial nephritis |
| Aminopenicillin Drugs |
Ampicillin (IV/PO), Amoxicillin (PO) |
| Aminopenicillin covers |
Enterococci, E.coli, H. influenza, Proteus, Klebsiella |
| Aminopenicillin W/P |
Renal Insufficiency & Cephalosporin allergy |
| Aminopenicillin ADR |
Rash & GI upset |
| Extended-spectrum ureidopenicillins drugs & forms |
Pipercillin (IV) usually used in combination! |
| Extended-spectrum ureidopenicillins covers |
Anaerobes, enterobactericacae & pseudomonas |
| Extended-spectrum ureidopenicillins W/P |
Severe renal impairment & allergies to cephalosporins |
| Extended-spectrum ureidopenicillins ADRs |
GI & dermatology |
| B-lactamase inhibitor drugs |
ampicillin/sulbactam (Unasyn - IV) Pipercillin/Tazobactam (Zosyn-IV) Aoxicillin/clavulante (Augmentin-PO) |
| Unasyn ingrediants |
Ampicillin & sulbactam |
| Zosyn ingrediants |
Pipercillin & tazobactam |
| Augmentin ingrediants |
Amoxicillin & Clavulanate |
| B-lactamase inhibitor SE |
Diarrhea (increased with clavulanate) |
| Penicillin Class drug interactions |
Decrease OCP efficiancy. Increases warfarins effect. |
| Penicillin Class ADRs |
Seizure potential with high doses. Inhibit platelet aggregation. |
| Cephalosporins types |
1st generation-4th generation |
| Cephalosporins pregnancy categroy |
B |
| Cephalosporins ADRs |
Increase C. difficile colitis & VRE |
| 1st generation cephalosporins drugs & forms |
Cefazolin - Ancef(IV) & Cephalexin - Keflex (PO) |
| Cefazolin |
Ancef |
| Cephalexin |
Keflex |
| 1st generation cephalosporins coverage |
Better gm + |
| 1st generation cephalosporins uses |
surgical prophylaxis, SSSIs & UTI |
| 2nd generation cephalosporins coverage |
Less gram + & more gram - |
| 2nd generation cephalosporins drugs |
Cefuroxime (Ceftin) - PO. Cefotetan (Cefotan) - IV. |
| Cefuroxime (Ceftin) covers |
strep, haemophilus, E. coli, Proteus, Klebsiella |
| Cefuroxime (Ceftin)uses |
URI/L RTIs, Otitis Media, COPD exacerbations, sinusitis. |
| Cefuroxime |
Ceftin |
| Cefotetan |
Cefotan |
| Cefotetan (Cefotan) covers |
B. frgilis & other bowel anaerobes |
| Cefotetan (Cefotan) uses |
abdominal infections, bowel surgery prophylaxis, OB/GYN infections (PID) |
| 3rd generation cephalosporin coverage |
weak gram + & good gram - |
| 3rd generation cephalosporin drugs |
Ceftriaxone (Rocephin) - IV. Ceftazadime (Fortaz - IV. Cefpodoxime (Vantin) - PO. Cefixime (Suprax) - PO |
| Ceftriaxone |
Rocephin |
| Ceftriaxone (Rocephin) ADRs |
Biliary sludging b/c its eliminated via biliary excretion |
| Ceftriaxone (Rocephin) coverage |
Severe gram (-) infection & Meningitis |
| Ceftazadime |
Fortaz |
| Ceftazadime (Fortaz) coverage |
Pseudomonas |
| Cefpodoxime |
Vantin |
| Cefixime |
Suprax |
| Cefpodoxime (Vantin) & Cefixime (Suprax) coverage |
URIs & RTIs |
| 4th Generation Cephalosporin drug & form |
Cefepime (IV) |
| Cefepime covers |
Pseudomonas, gram (-) rods (enterobacter, serratia & citrobacter). |
| Cefepime uses |
Febrile neutropenia, hospital acquired pneumonia, serious gram (-) infections. |
| Carbapenems drugs |
Imipenem/cilastatin (Primaxin) - IV. Meropenem (IV). Ertapenem (Invanz)- IV. |
| Primaxin |
imipenem/cilastatin |
| Carbapenems covers |
gram +'s including MSSA, grams -'s & anaerobes. |
| Primaxin (Imipenem/cilastatin) uses |
pseudomonas & polymicrobial infections. |
| Primaxin (Imipenem/cilastatin) ADR |
N/V & decreases seizure threshhold. |
| Primaxin (Imipenem/cilastatin) W/P |
Hx of seizures |
| Primaxin (Imipenem/cilastatin) pregnancy category |
C |
| Meropenem ADR |
Less seizures & N/V |
| Meropenem pregnancy category |
B |
| Meropenem coverage decreased in |
Staph & strep |
| Ertapenem |
Invanz |
| Ertapenem (Invanz) does not cover |
pseudomonas |
| Monobactam drug & form |
Aztreonam (Azactam) - IV |
| Aztreonam |
Azactam |
| Aztreonam (Azactam) coverage |
Gram negative ONLY |
| Aztreonam (Azactam) pregnancy category |
B |
| Aztreonam (Azactam) SE |
Well tolerated |
| Aminoglycoside drugs |
Gentamicin, Tobramycin & amikacin (all IV; not absorbed well) |
| Aminoglycoside coverage |
Gram - (Pseudomonas) |
| Aminoglycoside decreased effectivness by |
Abscesses |
| Aminoglycoside Pregnancy category |
D |
| Aminoglycoside uses |
Always used in combo: serious gram (-) infections or b-lactam for synergy |
| Macrolides drugs |
Erythromycin (Iv, PO, Opth). Clarithromycin (Biaxin) - PO. Azithromycin (Zithromax) - IV/PO |
| Clarithromycin |
Biaxin |
| Azithromycin |
Zithromax |
| Macrolides Pregnancy category |
B (eryth, Azith) & C (Clarith) |
| Macrolides coverage |
pneumococcus, atypicals, H. influenza |
| Macrolides Uses |
OM, CAP, COPD, STD |
| Macrolides ADR |
GI (take with food) & QT prolongation |
| Clarithromycin (Biaxin) DOC |
Eryth-sensitive strains of streptococci |
| Azithromycin (Zithromax) DOC |
H. Influenza & Chlamydia |
| Azithromycin (Zithromax) half life |
68 hours |
| Fluoroquinolone drugs |
Ofloxacin, ciprofloxacin (Cipro), Levofloxacin (Levaquin), Moxifloxacin (Avelox), Gatifloxacin (Tequin), Gemifloxacin (Factive) |
| Fluoroquinolone coverage |
good gram (-), alright gram (+) |
| Fluoroquinolone DOC |
Legionella |
| Cipro & Levaquin cover |
Pseudomonas |
| Fluoroquinolone pregnancy category |
C |
| Fluoroquinolone CI |
<18y.o. (arthropathy) |
| Fluoroquinolone ADR |
N/V/D, CNS (HA, restlessness), decrease seizure threshhold, tendon rupture (spontaneous - achilles), increase in AST/ALT |
| Fluoroquinolone DI |
Aluminum/Mg antacids, sulcralfate, Ca2+, Fe2+ & Zinc - decrease absorption. Increases the effect of warfarin (except moxifloxacin & gatifloxacin) |
| Fluoroquinolone uses |
CAP (includes atypicals), UTIs/pyelonephritis, COPD, acute exacerbation of chronic bronchitis, sinusitis |
| Tetracycline drugs |
tetracycline, doxycycline, minocycline |
| Tetracycline coverage |
Broad - including rickettsia, mycoplasma & chlamydia |
| Tetracycline pregnancy category |
D |
| Tetracycline CI |
< 8 y.o. (permanent discoloration of the teeth & inhibits bone growth) |
| Tetracycline Use |
CAP, STD (Chlamydia), syphilis (pen-allergic pts.), Lyme dz, acne, community acquired MRSA |
| Tetracycline ADR |
GI, photosensitivity, erosive esophagitis, vestibular sx (drunk/off balance), liver damage (rare) |
| Tetracycline DI |
Increased effect of warfarin |
| Vancomycin Forms |
IV & PO(C. difficile only) |
| Vancomycin MOA |
Inhibits cell wall growth ("slowly" cidal) |
| Vancomycin coverage |
gram +'s (MRSA, MRSE) & mild-mod anaerobic |
| Vancomycin pregnancy category |
C |
| Vancomycin ADR |
Redman syndrome (nonallergic rash on face/chest, flushing & hypotension), reversible neutopenia |
| Vancomycin administration |
Given slowly (over an hour) |
| Vancomycin special abilities |
Penetrates CSF |
| Clindamycin |
Cleocin |
| Clindamycin (Cleocin) forms |
IV, PO, Topical (acne), Vaginal |
| Clindamycin (Cleocin) class |
Lincomycin |
| Clindamycin (Cleocin) MOA |
Inhibits protein synthesis |
| Clindamycin (Cleocin) Coverage |
**anaerobes** Strep & S. aureus (MRSA) |
| Clindamycin (Cleocin) use |
anaerobic abscess, abdominal infections & Gyn |
| Clindamycin (Cleocin) ADR |
N/V/D & rash - can cause C. Diff |
| Metronidazole |
Flagyl |
| Metronidazole (Flagyl) MOA |
Inhibits DNA synthesis |
| Clindamycin (Cleocin) coverage |
anaerobes & ameoba |
| Clindamycin (Cleocin) uses |
Abdominal abscess, C. diff, Rx trich, & H. pylori |
| Clindamycin (Cleocin) Pregnancy category |
B (avoid 1st trimester) |
| Clindamycin (Cleocin) special abilities |
Penetrate CSF |
| Clindamycin (Cleocin) ADR |
N/V and alcohol reaction |
| TMP/SMZ |
Trimethoprim/Sulfamethoxazole |
| TMP/SMZ (Trimethoprim/Sulfamethoxazole) forms |
PO or IV |
| TMP/SMZ (Trimethoprim/Sulfamethoxazole) MOA |
Inhibits folic acid synthesis (static) |
| TMP/SMZ (Trimethoprim/Sulfamethoxazole) pregnancy category |
B but at 3rd trimester - term = D |
| TMP/SMZ (Trimethoprim/Sulfamethoxazole) coverage |
Staph, strep, GNR's & Pneumocystis (prophylaxis for HIV pt.) |
| TMP/SMZ (Trimethoprim/Sulfamethoxazole) uses |
UTIs, gram - infections, MRSA |
| TMP/SMZ (Trimethoprim/Sulfamethoxazole) DOC |
PCP |
| TMP/SMZ (Trimethoprim/Sulfamethoxazole) ADR |
Rash, CNS disturbances, photosensitivity, GI Sx. |
| TMP/SMZ (Trimethoprim/Sulfamethoxazole) Increase toxcity of... |
warfarin, oral hypoglycemics, phenytoin, methotrexate, cyclosporin |
| Rifampin Form |
PO |
| Rifampin MOA |
Inhibits bacterial synthesis |
| Rifampin Uses |
TB, Meningococcal prophylaxis, nasal carriers of MRSA |
| Rifampin ADR |
GI upset, rash, turns secretions red-orange-brown, hepatotoxic, potent cyt P450 inhibitor |
| Linezolid |
Zyvox |
| Linezolid (Zyvox) forms |
IV & PO (100% available) |
| Linezolid (Zyvox) class |
Oxazolidinone |
| Linezolid (Zyvox) coverage |
Staph (MRSA), Coag (-) staph, strept, enterococci (VRE). Minor against anaerobes |
| Linezolid (Zyvox) ADR |
Thrombocytopenia (reversible) or anemia |
| Linezolid (Zyvox) uses |
variety of infections from MRSA and VRE |
| Synercid |
Quinupristin/Dalfopristin |
| Synercide Quinupristin/Dalfopristin class |
Streptogramin |
| Synercide Quinupristin/Dalfopristin form |
IV via central line only! |
| Synercide Quinupristin/Dalfopristin coverage |
MRSA, VRE |
| Synercide Quinupristin/Dalfopristin ADR |
Myalgia, arthalgia |
| Synercide Quinupristin/Dalfopristin amount used |
Rarely |
| Daptomycin Form |
IV |
| Daptomycin coverage |
MRSA |
| Daptomycin use |
complicated skin & soft tissue infection |
| Tygecycline coverage |
MRSA, VRE, strep, enteric GNRs, bowel anaerobes |
| Mupirocin |
Bactroban |
| Mupirocin (Bactroban) form |
Topical |
| Mupirocin (Bactroban) use |
Impetigo due to S.aureus, group A strept (pyogenese) or decolonize the nasal passages of MRSA carriers (+/-) |
| Nitrofurantoin |
Macrodantin |
| Nitrofurantoin (Macrodantin) coverage |
gram +'s, enterococci, E. coli |
| Nitrofurantoin (Macrodantin) Pregnancy |
B |
| Nitrofurantoin (Macrodantin) DI |
decreased absorption with antacids |
| Nitrofurantoin (Macrodantin) W/P |
G6PD deficiency = interstitial pulmonary fibrosis with chronic use. |
| Nitrofurantoin (Macrodantin) use |
ONLY UTIS - Tx/prophylaxis |
| Bacteria that must be treated for > 4 weeks |
S. Aureus bacteremia, endocarditis, ostomyelitis |
| Anti-Staphylococcal |
**Nafcillin, oxacillin, dicloxacillin, cefazolin |
| Anti-MRSA |
Vancomycin, Clindamycin, Doxycycline, TMP/SMZ, Linezolid, Quinupristin/dalfopristin, daptomycin, tygecycline. |
| Anti-anaerobic |
Metronidazole, clindamycin, carbapenems, ceftotetan, Penicillin, B-lactamase inhibitors |
| Anti-pseudomonal |
pipercillin/tazobactam, aminoglycosides, ceftazadime, cefepime, imipenem, meropenem, ciprofloxacin, levofloxacin. |